This pilot clinical trial protocol aims to investigate the effect of a ‘ketogenic-mimicking diet’ on neural network stability, mood, and biomarker outcomes in the setting of bipolar disorder.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.